Treatments for elderly cancer patients and reforms to social security systems in Japan
In Japan, the population aged 65 years and above accounts for 29% of the total population. Furthermore, the number of cancer patients among the elderly is increasing. Geriatric oncology is a discipline that deals with appropriate care for elderly cancer patients based on their characteristics. The I...
Uložené v:
| Vydané v: | International journal of clinical oncology Ročník 27; číslo 2; s. 310 - 315 |
|---|---|
| Hlavní autori: | , |
| Médium: | Journal Article |
| Jazyk: | English |
| Vydavateľské údaje: |
Singapore
Springer Singapore
01.02.2022
Springer Nature B.V |
| Predmet: | |
| ISSN: | 1341-9625, 1437-7772, 1437-7772 |
| On-line prístup: | Získať plný text |
| Tagy: |
Pridať tag
Žiadne tagy, Buďte prvý, kto otaguje tento záznam!
|
| Abstract | In Japan, the population aged 65 years and above accounts for 29% of the total population. Furthermore, the number of cancer patients among the elderly is increasing. Geriatric oncology is a discipline that deals with appropriate care for elderly cancer patients based on their characteristics. The International Society of Geriatric Oncology considers education, treatment, research, and partnership building areas of significance and priority for policy goals. In Japan, the Third Term of the Basic Plan to Promote Cancer Control is an initiative to improve the infrastructure and health services involved in cancer care. Content related to “cancer in the elderly” was added to establish guidelines for treating cancer in the elderly. Thus far, “Clinical Practice Guidelines of Cancer Drug Therapies for the Elderly” have been published. With the increasing age of the population, social security expenditures will increase substantially after the fiscal year 2022. Reforms to social security systems, such as pensions, medical care, and nursing care, are underway. It is important to enhance cooperation between oncology and geriatrics and to support cooperative systems among families and medical professionals to promote geriatric oncology. Since the working-age population and the total population have begun to decline, Japan is facing many challenges. As a leader of a super-aging society, Japan has the potential to share its experience on a global scale and address potential long-term outcomes. |
|---|---|
| AbstractList | In Japan, the population aged 65 years and above accounts for 29% of the total population. Furthermore, the number of cancer patients among the elderly is increasing. Geriatric oncology is a discipline that deals with appropriate care for elderly cancer patients based on their characteristics. The International Society of Geriatric Oncology considers education, treatment, research, and partnership building areas of significance and priority for policy goals. In Japan, the Third Term of the Basic Plan to Promote Cancer Control is an initiative to improve the infrastructure and health services involved in cancer care. Content related to “cancer in the elderly” was added to establish guidelines for treating cancer in the elderly. Thus far, “Clinical Practice Guidelines of Cancer Drug Therapies for the Elderly” have been published. With the increasing age of the population, social security expenditures will increase substantially after the fiscal year 2022. Reforms to social security systems, such as pensions, medical care, and nursing care, are underway. It is important to enhance cooperation between oncology and geriatrics and to support cooperative systems among families and medical professionals to promote geriatric oncology. Since the working-age population and the total population have begun to decline, Japan is facing many challenges. As a leader of a super-aging society, Japan has the potential to share its experience on a global scale and address potential long-term outcomes. In Japan, the population aged 65 years and above accounts for 29% of the total population. Furthermore, the number of cancer patients among the elderly is increasing. Geriatric oncology is a discipline that deals with appropriate care for elderly cancer patients based on their characteristics. The International Society of Geriatric Oncology considers education, treatment, research, and partnership building areas of significance and priority for policy goals. In Japan, the Third Term of the Basic Plan to Promote Cancer Control is an initiative to improve the infrastructure and health services involved in cancer care. Content related to "cancer in the elderly" was added to establish guidelines for treating cancer in the elderly. Thus far, "Clinical Practice Guidelines of Cancer Drug Therapies for the Elderly" have been published. With the increasing age of the population, social security expenditures will increase substantially after the fiscal year 2022. Reforms to social security systems, such as pensions, medical care, and nursing care, are underway. It is important to enhance cooperation between oncology and geriatrics and to support cooperative systems among families and medical professionals to promote geriatric oncology. Since the working-age population and the total population have begun to decline, Japan is facing many challenges. As a leader of a super-aging society, Japan has the potential to share its experience on a global scale and address potential long-term outcomes.In Japan, the population aged 65 years and above accounts for 29% of the total population. Furthermore, the number of cancer patients among the elderly is increasing. Geriatric oncology is a discipline that deals with appropriate care for elderly cancer patients based on their characteristics. The International Society of Geriatric Oncology considers education, treatment, research, and partnership building areas of significance and priority for policy goals. In Japan, the Third Term of the Basic Plan to Promote Cancer Control is an initiative to improve the infrastructure and health services involved in cancer care. Content related to "cancer in the elderly" was added to establish guidelines for treating cancer in the elderly. Thus far, "Clinical Practice Guidelines of Cancer Drug Therapies for the Elderly" have been published. With the increasing age of the population, social security expenditures will increase substantially after the fiscal year 2022. Reforms to social security systems, such as pensions, medical care, and nursing care, are underway. It is important to enhance cooperation between oncology and geriatrics and to support cooperative systems among families and medical professionals to promote geriatric oncology. Since the working-age population and the total population have begun to decline, Japan is facing many challenges. As a leader of a super-aging society, Japan has the potential to share its experience on a global scale and address potential long-term outcomes. In Japan, the population aged 65 years and above accounts for 29% of the total population. Furthermore, the number of cancer patients among the elderly is increasing. Geriatric oncology is a discipline that deals with appropriate care for elderly cancer patients based on their characteristics. The International Society of Geriatric Oncology considers education, treatment, research, and partnership building areas of significance and priority for policy goals. In Japan, the Third Term of the Basic Plan to Promote Cancer Control is an initiative to improve the infrastructure and health services involved in cancer care. Content related to “cancer in the elderly” was added to establish guidelines for treating cancer in the elderly. Thus far, “Clinical Practice Guidelines of Cancer Drug Therapies for the Elderly” have been published. With the increasing age of the population, social security expenditures will increase substantially after the fiscal year 2022. Reforms to social security systems, such as pensions, medical care, and nursing care, are underway. It is important to enhance cooperation between oncology and geriatrics and to support cooperative systems among families and medical professionals to promote geriatric oncology. Since the working-age population and the total population have begun to decline, Japan is facing many challenges. As a leader of a super-aging society, Japan has the potential to share its experience on a global scale and address potential long-term outcomes. |
| Author | Furuse, Junji Nagashima, Fumio |
| Author_xml | – sequence: 1 givenname: Fumio orcidid: 0000-0002-5940-4363 surname: Nagashima fullname: Nagashima, Fumio email: fnagashi@ks.kyorin-u.ac.jp organization: Department of Medical Oncology, Faculty of Medicine, Kyorin University – sequence: 2 givenname: Junji surname: Furuse fullname: Furuse, Junji organization: Department of Medical Oncology, Faculty of Medicine, Kyorin University |
| BackLink | https://www.ncbi.nlm.nih.gov/pubmed/35098370$$D View this record in MEDLINE/PubMed |
| BookMark | eNp9kU1vFSEUhompsR_6B1wYEjduRg8MzIGNiWn8TBM31S3hMkylmYErMCb338vtbf3oogsC4Tzvy8s5p-QopugJec7gNQPAN4UBE9gBZ22B1h08IidM9NghIj9q516wTg9cHpPTUq4BGA6SPyHHvQSteoQT8v0ye1sXH2uhU8rUz6PP8446G53PdGtruKnZONLsG7EUWhMtyQU70-LdmkPd0bIr1bdSiPSL3dr4lDye7Fz8s9v9jHz78P7y_FN38fXj5_N3F50TWtXOKcemzTQ4GDUKlNxZQDUxVFrodi-c13IQU8_lCKDdtBm9tsKOKB2wDevPyNuD73bdLH50LWu2s9nmsNi8M8kG838lhh_mKv0ySgHjCM3g1a1BTj9XX6pZQnF-nm30aS2GD1zw9jRiQ1_eQ6_TmmP73p6SgiFXslEv_k30J8pdyxugDoDLqZTWU-NCbW1O-4BhNgzMfrrmMF3Tpmtupmv2Un5Peuf-oKg_iEqD45XPf2M_oPoNpH24GQ |
| CitedBy_id | crossref_primary_10_3390_cancers14246076 crossref_primary_10_1200_GO_25_00161 crossref_primary_10_1007_s00384_023_04440_7 crossref_primary_10_3390_healthcare13060589 crossref_primary_10_1186_s12890_022_02249_8 crossref_primary_10_3390_cancers14246229 crossref_primary_10_1111_iju_15180 crossref_primary_10_1002_cam4_70186 crossref_primary_10_3390_land12091716 crossref_primary_10_1093_mr_roaf030 crossref_primary_10_1111_ases_13331 crossref_primary_10_1016_j_jds_2024_04_006 crossref_primary_10_1007_s43441_023_00573_7 crossref_primary_10_1186_s12876_025_03824_z crossref_primary_10_1007_s10147_024_02618_9 crossref_primary_10_1007_s12328_023_01834_6 |
| Cites_doi | 10.1001/jama.1963.03060120024016 10.1016/S1470-2045(20)30473-3 10.1007/s00520-015-2970-8 10.1016/j.critrevonc.2007.05.001 10.1177/107327480701400103 10.1371/journal.pone.0115060 10.1016/j.ejca.2020.11.022 10.1016/j.canep.2014.07.005 10.1192/bjp.114.512.797 10.1001/jamaoncol.2019.4728 10.1093/annonc/mdg013 10.1634/theoncologist.2009-0290 10.1046/j.1532-5415.2003.51465.x 10.1016/S0140-6736(21)01789-X 10.1186/s12877-021-02028-w 10.1200/JCO.2015.65.4327 10.1200/JCO.2013.54.8347 10.1016/0022-3956(75)90026-6 10.1016/S1040-8428(00)00089-5 10.1016/j.jgo.2017.07.004 10.1016/0021-9681(87)90171-8 10.1200/JCO.2018.78.8687 10.1200/JCO.2000.18.13.2529 10.1111/j.1532-5415.1968.tb02103.x 10.1200/JCO.2013.51.1345 10.1200/JCO.2009.27.0579 10.1093/gerona/glw234 10.1002/cncr.26646 |
| ContentType | Journal Article |
| Copyright | The Author(s) under exclusive licence to Japan Society of Clinical Oncology 2021 2021. The Author(s) under exclusive licence to Japan Society of Clinical Oncology. Copyright Springer Nature B.V. Feb 2022 |
| Copyright_xml | – notice: The Author(s) under exclusive licence to Japan Society of Clinical Oncology 2021 – notice: 2021. The Author(s) under exclusive licence to Japan Society of Clinical Oncology. – notice: Copyright Springer Nature B.V. Feb 2022 |
| DBID | AAYXX CITATION CGR CUY CVF ECM EIF NPM 3V. 7TO 7X7 7XB 88E 8AO 8C1 8FI 8FJ 8FK 8G5 ABUWG AFKRA AZQEC BENPR CCPQU DWQXO FYUFA GHDGH GNUQQ GUQSH H94 K9. M0S M1P M2O MBDVC PHGZM PHGZT PJZUB PKEHL PPXIY PQEST PQQKQ PQUKI PRINS Q9U 7X8 5PM |
| DOI | 10.1007/s10147-021-02099-0 |
| DatabaseName | CrossRef Medline MEDLINE MEDLINE (Ovid) MEDLINE MEDLINE PubMed ProQuest Central (Corporate) Oncogenes and Growth Factors Abstracts Health & Medical Collection ProQuest Central (purchase pre-March 2016) Medical Database (Alumni Edition) ProQuest Pharma Collection Public Health Database Hospital Premium Collection Hospital Premium Collection (Alumni Edition) ProQuest Central (Alumni) (purchase pre-March 2016) Research Library (Alumni Edition) ProQuest Central (Alumni) ProQuest Central UK/Ireland ProQuest Central Essentials ProQuest Central ProQuest One Community College ProQuest Central Korea Health Research Premium Collection Health Research Premium Collection (Alumni) ProQuest Central Student Research Library Prep AIDS and Cancer Research Abstracts ProQuest Health & Medical Complete (Alumni) Health & Medical Collection (Alumni Edition) PML(ProQuest Medical Library) Proquest Research Library Research Library (Corporate) ProQuest Databases ProQuest One Academic ProQuest Health & Medical Research Collection ProQuest One Academic Middle East (New) One Health & Nursing ProQuest One Academic Eastern Edition (DO NOT USE) ProQuest One Academic (retired) ProQuest One Academic UKI Edition ProQuest Central China ProQuest Central Basic MEDLINE - Academic PubMed Central (Full Participant titles) |
| DatabaseTitle | CrossRef MEDLINE Medline Complete MEDLINE with Full Text PubMed MEDLINE (Ovid) Research Library Prep ProQuest Central Student Oncogenes and Growth Factors Abstracts ProQuest One Academic Middle East (New) ProQuest Central Essentials ProQuest Health & Medical Complete (Alumni) ProQuest Central (Alumni Edition) ProQuest One Community College ProQuest One Health & Nursing Research Library (Alumni Edition) ProQuest Pharma Collection ProQuest Central China ProQuest Central ProQuest Health & Medical Research Collection Health Research Premium Collection Health and Medicine Complete (Alumni Edition) ProQuest Central Korea Health & Medical Research Collection AIDS and Cancer Research Abstracts ProQuest Research Library ProQuest Central (New) ProQuest Medical Library (Alumni) ProQuest Public Health ProQuest Central Basic ProQuest One Academic Eastern Edition ProQuest Hospital Collection Health Research Premium Collection (Alumni) ProQuest Hospital Collection (Alumni) ProQuest Health & Medical Complete ProQuest Medical Library ProQuest One Academic UKI Edition ProQuest One Academic ProQuest One Academic (New) ProQuest Central (Alumni) MEDLINE - Academic |
| DatabaseTitleList | MEDLINE - Academic MEDLINE Research Library Prep |
| Database_xml | – sequence: 1 dbid: NPM name: PubMed url: http://www.ncbi.nlm.nih.gov/entrez/query.fcgi?db=PubMed sourceTypes: Index Database – sequence: 2 dbid: BENPR name: ProQuest Central url: https://www.proquest.com/central sourceTypes: Aggregation Database |
| DeliveryMethod | fulltext_linktorsrc |
| Discipline | Medicine |
| EISSN | 1437-7772 |
| EndPage | 315 |
| ExternalDocumentID | PMC8801270 35098370 10_1007_s10147_021_02099_0 |
| Genre | Journal Article Review |
| GeographicLocations | Japan |
| GeographicLocations_xml | – name: Japan |
| GrantInformation_xml | – fundername: Japan Society for the Promotion of Science grantid: Grant Number JP20K12049 – fundername: ; grantid: Grant Number JP20K12049 |
| GroupedDBID | --- -Y2 -~C .55 .86 .VR 06C 06D 0R~ 0VY 1N0 1SB 2.D 203 28- 29J 29~ 2J2 2JN 2JY 2KG 2LR 2P1 2VQ 2~H 30V 36B 4.4 406 408 409 40D 40E 53G 5GY 5QI 5VS 67Z 6NX 7X7 88E 8AO 8C1 8FI 8FJ 8G5 8TC 8UJ 95- 95. 95~ 96X AABHQ AACDK AAHNG AAIAL AAJBT AAJKR AANXM AANZL AAPKM AARHV AARTL AASML AATNV AATVU AAUYE AAWCG AAYIU AAYQN AAYTO AAYZH ABAKF ABBBX ABBRH ABBXA ABDBE ABDZT ABECU ABFSG ABFTV ABHLI ABHQN ABIPD ABJNI ABJOX ABKCH ABKTR ABMNI ABMQK ABNWP ABPLI ABQBU ABQSL ABRTQ ABSXP ABTEG ABTKH ABTMW ABULA ABUWG ABWNU ABXPI ACAOD ACDTI ACGFS ACHSB ACHXU ACKNC ACMDZ ACMLO ACOKC ACOMO ACPIV ACPRK ACSNA ACSTC ACUDM ACZOJ ADBBV ADHHG ADHIR ADHKG ADJJI ADKNI ADKPE ADRFC ADTPH ADURQ ADYFF ADZKW AEBTG AEFIE AEFQL AEGAL AEGNC AEJHL AEJRE AEKMD AEMSY AENEX AEOHA AEPYU AESKC AETLH AEVLU AEXYK AEZWR AFBBN AFDZB AFEXP AFHIU AFKRA AFLOW AFOHR AFQWF AFWTZ AFZKB AGAYW AGDGC AGGDS AGJBK AGMZJ AGQEE AGQMX AGQPQ AGRTI AGWIL AGWZB AGYKE AHAVH AHBYD AHIZS AHMBA AHPBZ AHSBF AHWEU AHYZX AIAKS AIGIU AIIXL AILAN AITGF AIXLP AJBLW AJRNO AJZVZ AKMHD ALIPV ALMA_UNASSIGNED_HOLDINGS ALWAN AMKLP AMXSW AMYLF AMYQR AOCGG ARMRJ ASPBG ATHPR AVWKF AXYYD AYFIA AZFZN AZQEC B-. BA0 BBWZM BDATZ BENPR BGNMA BPHCQ BSONS BVXVI CAG CCPQU COF CS3 CSCUP DDRTE DL5 DNIVK DPUIP DU5 DWQXO EBD EBLON EBS EIOEI EJD EMB EMOBN EN4 ESBYG FEDTE FERAY FFXSO FIGPU FINBP FNLPD FRRFC FSGXE FWDCC FYUFA G-Y G-Z GGCAI GGRSB GJIRD GNUQQ GNWQR GQ7 GQ8 GRRUI GUQSH GXS H13 HF~ HG5 HG6 HMCUK HMJXF HQYDN HRMNR HVGLF HZ~ I09 IHE IJ- IKXTQ IMOTQ IWAJR IXC IXD IXE IZIGR IZQ I~X I~Z J-C J0Z JBSCW JCJTX JZLTJ KDC KOV KOW KPH LAS LLZTM M1P M2O M4Y MA- N2Q N9A NB0 NDZJH NPVJJ NQJWS NU0 O9- O93 O9G O9I O9J OAM P19 P2P P9S PF0 PHGZM PHGZT PJZUB PPXIY PQQKQ PROAC PSQYO PT4 PT5 Q2X QOK QOR QOS R4E R89 R9I RHV RNI ROL RPX RRX RSV RZK S16 S1Z S26 S27 S28 S37 S3B SAP SCLPG SDE SDH SDM SHX SISQX SJYHP SMD SNE SNPRN SNX SOHCF SOJ SPISZ SRMVM SSLCW SSXJD STPWE SV3 SZ9 SZN T13 T16 TSG TSK TSV TT1 TUC U2A U9L UG4 UKHRP UOJIU UTJUX UZXMN VC2 VFIZW W23 W48 WJK WK8 X7M YLTOR Z45 ZMTXR ZOVNA ~A9 ~EX AAYXX AFFHD CITATION -53 -5E -5G -BR -EM 3V. AAAVM ADINQ CGR CUY CVF ECM EIF GQ6 NPM Z7U Z82 Z83 Z87 Z8O Z8V Z91 7TO 7XB 8FK H94 K9. MBDVC PKEHL PQEST PQUKI PRINS Q9U 7X8 PUEGO 5PM |
| ID | FETCH-LOGICAL-c498t-c8c1fbf6c0d974752ca078f178949bf64ce9564f325d009cfbde9a4ad75c01b13 |
| IEDL.DBID | RSV |
| ISICitedReferencesCount | 18 |
| ISICitedReferencesURI | http://www.webofscience.com/api/gateway?GWVersion=2&SrcApp=Summon&SrcAuth=ProQuest&DestLinkType=CitingArticles&DestApp=WOS_CPL&KeyUT=000750470000001&url=https%3A%2F%2Fcvtisr.summon.serialssolutions.com%2F%23%21%2Fsearch%3Fho%3Df%26include.ft.matches%3Dt%26l%3Dnull%26q%3D |
| ISSN | 1341-9625 1437-7772 |
| IngestDate | Tue Nov 04 01:57:48 EST 2025 Fri Sep 05 10:45:16 EDT 2025 Wed Nov 05 01:49:58 EST 2025 Wed Feb 19 02:07:50 EST 2025 Tue Nov 18 22:34:15 EST 2025 Sat Nov 29 08:04:29 EST 2025 Mon Jul 21 06:06:41 EDT 2025 |
| IsDoiOpenAccess | true |
| IsOpenAccess | true |
| IsPeerReviewed | true |
| IsScholarly | true |
| Issue | 2 |
| Keywords | Geriatric assessment Third term of the basic plan to promote cancer control Social security system Geriatric oncology Super-aging society |
| Language | English |
| License | 2021. The Author(s) under exclusive licence to Japan Society of Clinical Oncology. This article is made available via the PMC Open Access Subset for unrestricted research re-use and secondary analysis in any form or by any means with acknowledgement of the original source. These permissions are granted for the duration of the World Health Organization (WHO) declaration of COVID-19 as a global pandemic. |
| LinkModel | DirectLink |
| MergedId | FETCHMERGED-LOGICAL-c498t-c8c1fbf6c0d974752ca078f178949bf64ce9564f325d009cfbde9a4ad75c01b13 |
| Notes | ObjectType-Article-1 SourceType-Scholarly Journals-1 ObjectType-Feature-2 content type line 14 ObjectType-Review-3 content type line 23 |
| ORCID | 0000-0002-5940-4363 |
| OpenAccessLink | https://pubmed.ncbi.nlm.nih.gov/PMC8801270 |
| PMID | 35098370 |
| PQID | 2625417285 |
| PQPubID | 43390 |
| PageCount | 6 |
| ParticipantIDs | pubmedcentral_primary_oai_pubmedcentral_nih_gov_8801270 proquest_miscellaneous_2624200977 proquest_journals_2625417285 pubmed_primary_35098370 crossref_citationtrail_10_1007_s10147_021_02099_0 crossref_primary_10_1007_s10147_021_02099_0 springer_journals_10_1007_s10147_021_02099_0 |
| PublicationCentury | 2000 |
| PublicationDate | 2022-02-01 |
| PublicationDateYYYYMMDD | 2022-02-01 |
| PublicationDate_xml | – month: 02 year: 2022 text: 2022-02-01 day: 01 |
| PublicationDecade | 2020 |
| PublicationPlace | Singapore |
| PublicationPlace_xml | – name: Singapore – name: Japan – name: Tokyo |
| PublicationTitle | International journal of clinical oncology |
| PublicationTitleAbbrev | Int J Clin Oncol |
| PublicationTitleAlternate | Int J Clin Oncol |
| PublicationYear | 2022 |
| Publisher | Springer Singapore Springer Nature B.V |
| Publisher_xml | – name: Springer Singapore – name: Springer Nature B.V |
| References | JP Turner (2099_CR16) 2016; 24 2099_CR22 L Biganzoli (2099_CR33) 2017; 72 Japanese Society of Medical Oncology (2099_CR34) 2019 U Wedding (2099_CR8) 2007; 64 H Wildiers (2099_CR5) 2014; 32 M Extermann (2099_CR10) 2007; 14 MF Folstein (2099_CR17) 1975; 12 MP Lawton (2099_CR9) 1988; 24 RJ Maggiore (2099_CR15) 2010; 15 Y Tsubata (2099_CR26) 2021; 21 BS Linn (2099_CR13) 1968; 16 SG Mohile (2099_CR21) 2018; 36 C Owusu (2099_CR32) 2017; 8 S Borson (2099_CR18) 2003; 51 ME Charlson (2099_CR12) 1987; 40 L Balducci (2099_CR7) 2000; 35 S Katz (2099_CR6) 1963; 185 A Hurria (2099_CR28) 2016; 34 M Extermann (2099_CR29) 2012; 118 2099_CR37 2099_CR36 SK Pal (2099_CR11) 2010; 28 SG Mohile (2099_CR25) 2021 C Kenis (2099_CR31) 2014; 32 2099_CR35 SG Mohile (2099_CR23) 2020; 6 G Frasci (2099_CR14) 2000; 18 J Alexandre (2099_CR20) 2003; 14 P Soubeyran (2099_CR30) 2014 2099_CR1 M Extermann (2099_CR3) 2021; 22 G Blessed (2099_CR19) 1968; 114 2099_CR2 NML Battisti (2099_CR24) 2021; 144 M Iwamoto (2099_CR27) 2014; 38 2099_CR4 |
| References_xml | – volume: 185 start-page: 914 year: 1963 ident: 2099_CR6 publication-title: JAMA doi: 10.1001/jama.1963.03060120024016 – ident: 2099_CR22 – volume: 22 start-page: e29 issue: 1 year: 2021 ident: 2099_CR3 publication-title: Lancet Oncol doi: 10.1016/S1470-2045(20)30473-3 – volume: 24 start-page: 1831 issue: 4 year: 2016 ident: 2099_CR16 publication-title: Support Care Cancer doi: 10.1007/s00520-015-2970-8 – volume: 64 start-page: 1 issue: 1 year: 2007 ident: 2099_CR8 publication-title: Crit Rev Oncol Hematol doi: 10.1016/j.critrevonc.2007.05.001 – volume: 24 start-page: 609 issue: 4 year: 1988 ident: 2099_CR9 publication-title: Psychopharmacol Bull – volume: 14 start-page: 13 issue: 1 year: 2007 ident: 2099_CR10 publication-title: Cancer Control doi: 10.1177/107327480701400103 – year: 2014 ident: 2099_CR30 publication-title: PLoS ONE doi: 10.1371/journal.pone.0115060 – volume: 144 start-page: 269 year: 2021 ident: 2099_CR24 publication-title: Eur J Cancer doi: 10.1016/j.ejca.2020.11.022 – volume: 38 start-page: 511 issue: 5 year: 2014 ident: 2099_CR27 publication-title: Cancer Epidemiol doi: 10.1016/j.canep.2014.07.005 – volume: 114 start-page: 797 issue: 512 year: 1968 ident: 2099_CR19 publication-title: Br J Psychiatry doi: 10.1192/bjp.114.512.797 – volume: 6 start-page: 196 issue: 2 year: 2020 ident: 2099_CR23 publication-title: JAMA Oncol doi: 10.1001/jamaoncol.2019.4728 – ident: 2099_CR2 – volume: 14 start-page: 36 issue: 1 year: 2003 ident: 2099_CR20 publication-title: Ann Oncol doi: 10.1093/annonc/mdg013 – ident: 2099_CR4 – ident: 2099_CR36 – volume: 15 start-page: 507 issue: 5 year: 2010 ident: 2099_CR15 publication-title: Oncologist doi: 10.1634/theoncologist.2009-0290 – volume: 51 start-page: 1451 issue: 10 year: 2003 ident: 2099_CR18 publication-title: J Am Geriatr Soc doi: 10.1046/j.1532-5415.2003.51465.x – year: 2021 ident: 2099_CR25 publication-title: Lancet doi: 10.1016/S0140-6736(21)01789-X – volume: 21 start-page: 74 issue: 1 year: 2021 ident: 2099_CR26 publication-title: BMC Geriatr doi: 10.1186/s12877-021-02028-w – volume: 34 start-page: 2366 issue: 20 year: 2016 ident: 2099_CR28 publication-title: J Clin Oncol doi: 10.1200/JCO.2015.65.4327 – volume: 32 start-page: 2595 issue: 24 year: 2014 ident: 2099_CR5 publication-title: J Clin Oncol doi: 10.1200/JCO.2013.54.8347 – volume: 12 start-page: 189 issue: 3 year: 1975 ident: 2099_CR17 publication-title: J Psychiatr Res doi: 10.1016/0022-3956(75)90026-6 – volume: 35 start-page: 147 issue: 3 year: 2000 ident: 2099_CR7 publication-title: Crit Rev Oncol Hematol doi: 10.1016/S1040-8428(00)00089-5 – volume: 8 start-page: 356 issue: 5 year: 2017 ident: 2099_CR32 publication-title: J Geriatr Oncol doi: 10.1016/j.jgo.2017.07.004 – volume: 40 start-page: 373 issue: 5 year: 1987 ident: 2099_CR12 publication-title: J Chronic Dis doi: 10.1016/0021-9681(87)90171-8 – volume: 36 start-page: 2326 issue: 22 year: 2018 ident: 2099_CR21 publication-title: J Clin Oncol doi: 10.1200/JCO.2018.78.8687 – volume: 18 start-page: 2529 issue: 13 year: 2000 ident: 2099_CR14 publication-title: J Clin Oncol doi: 10.1200/JCO.2000.18.13.2529 – volume: 16 start-page: 622 issue: 5 year: 1968 ident: 2099_CR13 publication-title: J Am Geriatr Soc doi: 10.1111/j.1532-5415.1968.tb02103.x – volume: 32 start-page: 19 issue: 1 year: 2014 ident: 2099_CR31 publication-title: J Clin Oncol doi: 10.1200/JCO.2013.51.1345 – volume: 28 start-page: 4086 issue: 26 year: 2010 ident: 2099_CR11 publication-title: J Clin Oncol doi: 10.1200/JCO.2009.27.0579 – volume: 72 start-page: 922 issue: 7 year: 2017 ident: 2099_CR33 publication-title: J Gerontol A Biol Sci Med Sci doi: 10.1093/gerona/glw234 – ident: 2099_CR1 – volume: 118 start-page: 3377 issue: 13 year: 2012 ident: 2099_CR29 publication-title: Cancer doi: 10.1002/cncr.26646 – ident: 2099_CR35 – ident: 2099_CR37 – volume-title: Clinical practice guidelines of cancer drug therapies for the elderly year: 2019 ident: 2099_CR34 |
| SSID | ssj0017652 |
| Score | 2.381531 |
| SecondaryResourceType | review_article |
| Snippet | In Japan, the population aged 65 years and above accounts for 29% of the total population. Furthermore, the number of cancer patients among the elderly is... In Japan, the population aged 65 years and above accounts for 29% of the total population. Furthermore, the number of cancer patients among the elderly is... |
| SourceID | pubmedcentral proquest pubmed crossref springer |
| SourceType | Open Access Repository Aggregation Database Index Database Enrichment Source Publisher |
| StartPage | 310 |
| SubjectTerms | Aged Cancer Cancer Research Cancer therapies Geriatrics Humans Invited Review Invited Review Article Japan Medical Oncology Medical personnel Medicine Medicine & Public Health Neoplasms - therapy Oncology Patients Population Social Security Surgical Oncology |
| SummonAdditionalLinks | – databaseName: Health & Medical Collection dbid: 7X7 link: http://cvtisr.summon.serialssolutions.com/2.0.0/link/0/eLvHCXMwpV1Na9wwEB2aNIRe2iZNWzdpUCC3RMQfsmWfSihdSkmWHDZhb0bWB11YvNu1U-i_r0aWvWyW5tKrLWGLGUlPmpn3AM6FEVWSqdAVx1BmQk4LFUoL5BKpRWaEFI7E9YaPx_l0Wtz5C7fGp1X2a6JbqNVC4h35VWyBOkMxpfTL8hdF1SiMrnoJjR14ibLZ6Od8Ohy4Ip45xR3kLKOF7e-LZnzpXMQ4xQSFEKtHabi5MW2hze2kySeRU7chjd7871DewmsPRcl15zsH8ELXh7B_64Pt7-Bh0iehN8RCW6JR0Hv-h0h0lBXxjKwNEbUidjgW_DakXZDuFp40XhiPdFzRDZnV5IfdmesjuB99m3z9Tr0MA5WsyFsqcxmZymQyVHj4SGMpLK4wEc8LVtjnTGp7yGImiVNlEZs0ldKFYELxVIZRFSXvYbde1PojkESwNMkyIXSSskpHlS5Q6iNnxiI5rlgAUW-DUnqOcpTKmJdrdmW0W2ntVjq7lWEAF0OfZcfQ8Wzrk94mpZ-tTbk2SABnw2s7zzB4Imq9eHRtGEaSOA_gQ-cJw-cSi7qQRCgAvuEjQwPk8N58U89-Oi7vPHex_wAue29a_9a_R_Hp-VEcw6sYqzRccvkJ7LarR_0Z9uTvdtasTt0c-QuYhheV priority: 102 providerName: ProQuest |
| Title | Treatments for elderly cancer patients and reforms to social security systems in Japan |
| URI | https://link.springer.com/article/10.1007/s10147-021-02099-0 https://www.ncbi.nlm.nih.gov/pubmed/35098370 https://www.proquest.com/docview/2625417285 https://www.proquest.com/docview/2624200977 https://pubmed.ncbi.nlm.nih.gov/PMC8801270 |
| Volume | 27 |
| WOSCitedRecordID | wos000750470000001&url=https%3A%2F%2Fcvtisr.summon.serialssolutions.com%2F%23%21%2Fsearch%3Fho%3Df%26include.ft.matches%3Dt%26l%3Dnull%26q%3D |
| hasFullText | 1 |
| inHoldings | 1 |
| isFullTextHit | |
| isPrint | |
| journalDatabaseRights | – providerCode: PRVAVX databaseName: SpringerLink customDbUrl: eissn: 1437-7772 dateEnd: 99991231 omitProxy: false ssIdentifier: ssj0017652 issn: 1341-9625 databaseCode: RSV dateStart: 19970101 isFulltext: true titleUrlDefault: https://link.springer.com/search?facet-content-type=%22Journal%22 providerName: Springer Nature |
| link | http://cvtisr.summon.serialssolutions.com/2.0.0/link/0/eLvHCXMwnV3da9swED_6Mcpetm79mLssaLC31WBbsiU_dqVljDYtXVfyZmRZooHglDgd7L_fSZadZV0L3YvBlixb0sn3k-_udwCfpJElzarIBceEzEQ8zKtIIZCjSsvMSCUdiesZH43EeJxf-qCwpvN270yS7kv9R7BbzHhoXQoiG-8Z4kZ9E9WdsAkbrr7f9LYDnrk8O5apLMwR3vtQmX-3saqOHmDMh66Sf9lLnRo6ff1_HdiGVx52kqNWTt7Amq7fwta5N6zvwM1153DeEISxRNvk3dNfRFmhmBPPvtoQWVcEO4FAtyGLGWn_uJPGJ8EjLS90QyY1-YZauN6FH6cn18dfQ59yIVQsF4tQCRWb0mQqquxGI02URAxhYi5yluN1pjRuqJihSVohOlOmrHQumax4qqK4jOkebNSzWr8DQiVLaZZJqWnKSh2XOrdpPQQziNp4xQKIu5EvlOcjt2kxpsWSSdkOWIEDVrgBK6IAPvf33LVsHE_WHnQTWviV2RQJSgSzSbnSAD72xbimrKFE1np27-owazXiPID9dv77x1ErcpRj43xFMvoKlq97taSe3DrebiGcnT-Aw04-lq_1eC8Onlf9PbxMbISGcywfwMZifq8_wAv1czFp5kNY52PujgKP4jgewuaXk9HlFZ6dJxdDt5J-A1U_ErA |
| linkProvider | Springer Nature |
| linkToHtml | http://cvtisr.summon.serialssolutions.com/2.0.0/link/0/eLvHCXMw1V1Nb9QwEB2VgoALnwUCBYwEJ4iaDydODgghoGrpduGwoN6C4w-xUpUtmy1V_1R_IzOOk9VS0VsPXBPvJk6e7efMzHsAL6WVdZrryBXHhNxGIix1pJDIpcrI3EolnYjrSIzHxcFB-XUNzvpaGEqr7OdEN1HrmaJv5FsJEnVOZkrZu6NfIblGUXS1t9DoYLFnTk9wy9a-3f2I7_dVkmx_mnzYCb2rQKh4WSxCVajY1jZXkSYunSVK4jJpY1GUvMTjXBncM3CbJplGAqJsrU0pudQiU1Fcxyn-7xW4ymknRKmCyZchaiFy5_BDGmlhiffri3R8qV7MRUgJERFVq4bR6kJ4jt2eT9L8K1LrFsDt2__bo7sDtzzVZu-7sXEX1kxzD67v-2SC-_B90ifZtwypOzNkWH54yhQNhDnzirMtk41m-PiQ3LdsMWNdlIG13viPdVrYLZs27DMyj2YDvl1Krx7AejNrzCNgqeRZmudSmjTjtYlrU5KVScEtMlWheQBx_84r5TXYyQrksFqqRxNOKsRJ5XBSRQG8Hn5z1CmQXNh6s8dA5WejtloCIIAXw2mcRyg4JBszO3ZtOEXKhAjgYYe84XIpskoSSQpArGByaEAa5atnmulPp1VeFC63IYA3PXqXt_XvXjy-uBfP4cbOZH9UjXbHe0_gZkIVKS6RfhPWF_Nj8xSuqd-LaTt_5sYngx-Xjeo_05Z1og |
| linkToPdf | http://cvtisr.summon.serialssolutions.com/2.0.0/link/0/eLvHCXMw1V1Nb9QwEB2VLap6oXy2oQWMBCeImg8nTg4IAe2K0rJaoYJ6C45jqytV2bLZgvrX-HXMOE5WS0VvPXBNnA8nz_ZLZuY9gBfSyDJOq8AWx_jcBMLPq0AhkYuVlqmRSloR1yMxGmUnJ_l4BX53tTCUVtnNiXairqaK_pHvRkjUOZkpJbvGpUWM94Zvz3_45CBFkdbOTqOFyKG-_IWfb82bgz181y-jaLh__OGj7xwGfMXzbO6rTIWmNKkKKuLVSaQkLpkmFFnOc9zOlcbvB27iKKmQjChTVjqXXFYiUUFYhjGe9xasCiQZfACr7_dH4y99DEOk1u-HFNP8HO_eley4wr2QC5_SIwKqXfWD5WXxCte9mrL5V9zWLofDjf_5Qd6FO46Es3ftqLkHK7q-D2ufXZrBA_h23KXfNwxJPdNkZX52yRQNkRlzWrQNk3XF8FEi7W_YfMra-ANrnCUga1WyGzap2SfkJPVD-HojvXoEg3pa6y1gseRJnKZS6jjhpQ5LnZPJScYNclhRcQ_C7v0Xyqmzk0nIWbHQlSbMFIiZwmKmCDx41R9z3mqTXNt6p8ND4eappliAwYPn_W6cYShsJGs9vbBtOMXQhPBgs0Vhf7kY-SbJJ3kglvDZNyD18uU99eTUqphnmc168OB1h-TFbf27F4-v78UzWEMwF0cHo8NtWI-oVMVm2O_AYD670E_gtvo5nzSzp26wMvh-07D-AwKhf78 |
| openUrl | ctx_ver=Z39.88-2004&ctx_enc=info%3Aofi%2Fenc%3AUTF-8&rfr_id=info%3Asid%2Fsummon.serialssolutions.com&rft_val_fmt=info%3Aofi%2Ffmt%3Akev%3Amtx%3Ajournal&rft.genre=article&rft.atitle=Treatments+for+elderly+cancer+patients+and+reforms+to+social+security+systems+in+Japan&rft.jtitle=International+journal+of+clinical+oncology&rft.au=Nagashima%2C+Fumio&rft.au=Furuse%2C+Junji&rft.date=2022-02-01&rft.eissn=1437-7772&rft.volume=27&rft.issue=2&rft.spage=310&rft_id=info:doi/10.1007%2Fs10147-021-02099-0&rft_id=info%3Apmid%2F35098370&rft.externalDocID=35098370 |
| thumbnail_l | http://covers-cdn.summon.serialssolutions.com/index.aspx?isbn=/lc.gif&issn=1341-9625&client=summon |
| thumbnail_m | http://covers-cdn.summon.serialssolutions.com/index.aspx?isbn=/mc.gif&issn=1341-9625&client=summon |
| thumbnail_s | http://covers-cdn.summon.serialssolutions.com/index.aspx?isbn=/sc.gif&issn=1341-9625&client=summon |